Literature DB >> 3875487

HLA antigens in ovarian adenocarcinoma patients.

M T Illeni, M Pasquali, G La Monica, S Böhm, D Rovini, E Di Re.   

Abstract

Sixty five patients affected by ovarian carcinoma, 40 controls with benign ovarian disease were typed for HLA A, B and C antigens and compared with 132 adult female blood donors. A highly significant increase in HLA B7 antigen (p = 0,0083) and a decrease in HLA A11, A28, B12 (p = 0,04; p = 0.03 respectively) in patients vs controls has been noticed. The comparison among the ovarian benign disease patients, and those with ovarian carcinoma and the healthy controls showed a decrease in the HLA A1 antigen frequency. Besides, the patients presented an increased and a decreased frequency of the A and O blood phenotypes respectively. These data confirm those of other Authors, and we can conclude that the neoplastic disease does not show a strong association with histocompatibility antigens.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3875487

Source DB:  PubMed          Journal:  Eur J Gynaecol Oncol        ISSN: 0392-2936            Impact factor:   0.196


  2 in total

1.  HLA-DQBl alleles and susceptibility to cervical squamous cell carcinoma in Southern Iranian patients.

Authors:  Alamtaj Samsami Dehaghani; Ali Amirzargar; Shirin Farjadian; Abbas Ghaderi
Journal:  Pathol Oncol Res       Date:  2002       Impact factor: 3.201

2.  The incidence and associations of malignancy in a large cohort of patients with biopsy-determined idiopathic inflammatory myositis.

Authors:  Vidya Limaye; Colin Luke; Graeme Tucker; Catherine Hill; Susan Lester; Peter Blumbergs; Peter Roberts-Thomson
Journal:  Rheumatol Int       Date:  2012-07-26       Impact factor: 2.631

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.